Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.
about
Development of Medical Countermeasures to Middle East Respiratory Syndrome CoronavirusReceptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice.Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseOptimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge.Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and DiseaseToward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus.Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus.Vaccines for the prevention against the threat of MERS-CoV.Middle East respiratory syndrome: current status and future prospects for vaccine development.Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review.Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infectionMERS-CoV spike nanoparticles protect mice from MERS-CoV infection.A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection.Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen.MERS-CoV: Understanding the Latest Human Coronavirus Threat.Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus.Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles.A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV
P2860
Q26700054-84CE0B40-07A8-44A1-A990-0D8DFAC6A047Q30399700-9E87BF57-0053-44FE-8795-8C831A3FC005Q30400066-E5E0EC02-BA57-4105-9746-B769E87DCC2BQ34468689-BC38A018-0BA6-4D13-837B-31484CB7A5EFQ35887626-FA99659E-47A1-4490-BED9-25157B0EF84CQ36252666-76AF1BF2-E37A-49AD-A590-6410A4DC04FCQ36433987-62DFF747-80C1-4E38-BCAC-4E88FB53A9F6Q37169882-ADBC2A62-466C-4DDF-AB5B-58A30D0504E5Q37264927-54190F75-E6B0-4470-B838-278637C2ED4DQ37512915-27D8BA6F-7E34-4DB9-9458-F5F478F7F61EQ37560824-C703A121-725D-41B4-A4B0-03B4A7EA7CB2Q38778044-3020B80B-D78D-4276-A0F1-441B0C577B4AQ38959242-DD9974F1-4E21-4E76-8BBF-5A6960906DE2Q39102732-05D21030-48DE-43B1-AD40-7C6E0CB16ADDQ39677274-650E2704-0B6A-41AE-99CE-F858F5C105EAQ40317741-F47A249E-5615-49AC-83C1-2878BCDC2914Q40503787-799BDE9B-090D-437D-8D44-DC8328652F1EQ47607374-EACBB2BB-012C-41BE-B537-EA4E52B16BA6Q51730564-EB86C402-69BA-4609-8FA1-B2A2A1DBE798Q53701486-CAC42A01-02BC-4831-A781-4494DB3B4E85Q54241763-4F8AEFF6-E7DC-429C-8B85-B5DA02A0A749Q55344910-8537DF88-852F-4F7D-9E96-CB3B6FA396E8Q58693121-AAFF6888-0610-416A-8E93-F9F736A20AB9
P2860
Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Identification of an ideal adj ...... piratory syndrome coronavirus.
@ast
Identification of an ideal adj ...... piratory syndrome coronavirus.
@en
type
label
Identification of an ideal adj ...... piratory syndrome coronavirus.
@ast
Identification of an ideal adj ...... piratory syndrome coronavirus.
@en
prefLabel
Identification of an ideal adj ...... piratory syndrome coronavirus.
@ast
Identification of an ideal adj ...... piratory syndrome coronavirus.
@en
P2093
P2860
P50
P356
P1476
Identification of an ideal adj ...... piratory syndrome coronavirus.
@en
P2093
Chien-Te K Tseng
Cuiqing Ma
Naru Zhang
Rudragouda Channappanavar
Sumaiya Tasneem
Tania Garron
Xinrong Tao
Yusen Zhou
P2860
P2888
P304
P356
10.1038/CMI.2015.03
P577
2015-02-02T00:00:00Z
P6179
1019869607